Cannabist Company Holdings Inc (CBST) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Cannabist Company Holdings Inc (CBST) has a cash flow conversion efficiency ratio of 0.161x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-24.59 Million ≈ $-17.79 Million USD) by net assets (CA$-152.95 Million ≈ $-110.64 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Cannabist Company Holdings Inc to measure how much of total assets are equity-financed.
Cannabist Company Holdings Inc - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Cannabist Company Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Cannabist Company Holdings Inc (CBST) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Cannabist Company Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cannabist Company Holdings Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shyam Century Ferrous Limited
NSE:SHYAMCENT
|
0.035x |
|
Medicon Hellas S.A.
AT:MEDIC
|
0.008x |
|
NextCell Pharma AB
ST:NXTCL
|
-0.162x |
|
PZ Cormay SA
WAR:CRM
|
-0.086x |
|
GMV Minerals Inc
V:GMV
|
-0.023x |
|
Volex Plc
LSE:VLX
|
0.052x |
|
IRLAB Therapeutics AB (publ)
ST:IRLAB-A
|
-0.787x |
|
M Cash Integrasi Tbk PT
JK:MCAS
|
-0.044x |
Annual Cash Flow Conversion Efficiency for Cannabist Company Holdings Inc (2018–2024)
The table below shows the annual cash flow conversion efficiency of Cannabist Company Holdings Inc from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see Cannabist Company Holdings Inc stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CA$-30.06 Million ≈ $-21.74 Million |
CA$-23.38 Million ≈ $-16.91 Million |
0.778x | +580.35% |
| 2023-12-31 | CA$65.35 Million ≈ $47.27 Million |
CA$7.47 Million ≈ $5.40 Million |
0.114x | +122.10% |
| 2022-12-31 | CA$206.81 Million ≈ $149.60 Million |
CA$-106.99 Million ≈ $-77.39 Million |
-0.517x | -54793.59% |
| 2021-12-31 | CA$550.08 Million ≈ $397.92 Million |
CA$-518.40K ≈ $-375.00K |
-0.001x | +99.48% |
| 2020-12-31 | CA$286.95 Million ≈ $207.57 Million |
CA$-52.27 Million ≈ $-37.81 Million |
-0.182x | +20.46% |
| 2019-12-31 | CA$266.93 Million ≈ $193.09 Million |
CA$-61.13 Million ≈ $-44.22 Million |
-0.229x | +81.58% |
| 2018-12-31 | CA$-986.97K ≈ $-713.96K |
CA$1.23 Million ≈ $887.68K |
-1.243x | -- |
About Cannabist Company Holdings Inc
The Cannabist Company Holdings Inc. cultivates, manufactures, and sells cannabis products and related services for the medical and adult-use markets in the United States and internationally. The company operates medical and/or adult use marijuana businesses and dispensaries. It also offers flowers, concentrates, edibles, oils and tablets, and accessories under the dreamt, Seed & Strain, Triple Se… Read more